Comparison of interferonα2β monotherapy with the combination of thymosinα1 and interferonα2β in the treatment of anti-HBe-positive chronic hepatitis B in Turkey.

Saruc, MYuceyar, HKucukmetin, NDemir, MAKandiloglu, AR2024-07-182024-07-180016-5085http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/2206EnglishComparison of interferonα2β monotherapy with the combination of thymosinα1 and interferonα2β in the treatment of anti-HBe-positive chronic hepatitis B in Turkey.Meeting Abstract